inositol and tirzepatide together Could affect period irregularity with PCOS? Microdosing Tirzepatide Program | No

doi: 10.1007/s00125-019-05039-w 7 MehtaAMarsoSPNeelandIJ

One of these changes is a slower heartbeat, which means your heart beats fewer than 60 times in a minute

Some clinicians have adopted this reasoning and prescribe both medications off-label, particularly phentermine combined with semaglutide or phentermine combined with tirzepatide

FDA-Noted Concerns: Increased heart rate Systemic vasodilatory reactions Limited clinical safety data Immunogenicity risk (antibody formation) Reported Side Effects: Injection site reactions (redness, swelling, itching) Headache Flushing Dizziness Nausea Water retention Serious Concerns: Potential for glucose metabolism disruption Theoretical cancer risk (GH/IGF-1 promote cell proliferation) Long-term safety unknown Regulatory Status United States: CJC-1295 is not FDA approved for any indication

Virtual Mesotherapy / Electroporation

GLP-1 receptor agonists as a pharmacological class are well-studied